Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07541404 · ClinicalTrials.gov registry record · NA
MMA Embolization With NeoCast for Subacute and Chronic Subdural Hematoma
A NA study, sponsored by Arsenal Medical.
- Not yet
- Registry status
- NA
- Development phase
- 360
- Enrollment target
NCT07541404: Clinical Trial NA study, sponsored by Arsenal Medical.
NCT07541404 is a NA study that has not yet begun recruiting, run by Arsenal Medical. The registered enrollment target is 360 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (74% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07541404, a NA study, has not yet begun recruiting, sponsored by Arsenal Medical.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 360 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the safety and efficacy of embolization of the middle meningeal artery (MMA) using the NeoCast Embolic System for treatment of symptomatic subacute or chronic subdural hematoma (SDH) adjunctive to surgery.
Primary Outcome
The Primary Effectiveness Endpoint is a non-inferiority comparison of the NeoCast and Onyx LES groups for treatment failure as defined by the occurrence of any of the following events: 1. Residual or re-accumulation of the SDH (≥10 mm) on 90-day scan post-treatment (assessed by a blinded, independent Imaging Core Lab); 2. Re-operation (after index procedure) or surgical rescue within 90 days post-treatment (CEC adjudicated); 3. Any new, major disabling stroke, myocardial infarction (MI) or deat
Interventions
- DEVICE NeoCast Embolic System
- DEVICE Onyx LES, an FDA-Approved Commercial Liquid Embolic
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 360 participants |
| Start Date | 2026-07 |
| Est. Completion | 2028-04 |
| Phase | NA |
What is known before NCT07541404 opens enrollment
NCT07541404 is an interventional study that assigns participants to a tested intervention. The registered 360 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (74% lower).
The record links to 0 conditions, and to 2 interventions - of which NeoCast Embolic System is the first listed.
NCT07541404 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07541404 about?
NCT07541404 is a clinical study titled "MMA Embolization With NeoCast for Subacute and Chronic Subdural Hematoma". The purpose of this study is to evaluate the safety and efficacy of embolization of the middle meningeal artery (MMA) using the NeoCast Embolic System for treatment of symptomatic subacute or chronic subdural hematoma (SDH) adjunctive to surgery.
What is the current status of trial NCT07541404?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 360 participants. The study started on 2026-07. Estimated completion is 2028-04.
What interventions are being tested in trial NCT07541404?
The interventions under investigation include: NeoCast Embolic System (DEVICE), Onyx LES, an FDA-Approved Commercial Liquid Embolic (DEVICE).
Who is sponsoring clinical trial NCT07541404?
This trial is sponsored by Arsenal Medical, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07541404's enrollment target sits among peer trials
360 284th of 2000 higher than 1,713 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02747836 · 360 participants
Ultrasound Analysis of Human Carpal Tunnel System
- NCT04089046 · 360 participants · NA
Telemedicine Enhanced Asthma Management - Uniting Providers for Teens (TEAM-UP for Teens)
- NCT04130503 · 360 participants · NA
The Recovery in Stroke Using PAP Study
- NCT04160000 · 360 participants · Phase 4
Treatment Of Atrial Fibrillation In Preserved Cardiac Function Heart Failure
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia